Clinical Predictors of Severe Cetuximab-Induced Rash: Observations from 933 Patients Enrolled in North Central Cancer Treatment Group Study N0147
- Citation:
- Oncology vol 77 (2) 120-123
- Year:
- 2009
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- R21CA134432, K24 CA131099, CA-37404, CA-35195, U10 CA037404, U10 CA035195, K24CA131099, CA-25225, R21 CA134432
- Corr. Author:
- Authors:
- Aminah Jatoi Erin M. Green Kendrith M. Jr. Rowland Daniel J. Sargent Steven R. Alberts
- Networks:
- Study
- NCCTG-N0147
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Cetuximab, Rash, Epidermal growth factor receptor inhibitors, Colon cancer